Acta Naturae · 2019 · 18 citations · 6 references
PharmacyCancer BiologyPharmaceuticsApoptosisDrug DeliveryTargeted Drug DeliveryBacteriophage VectorsCancer Drug DeliveryCell-penetrating PeptidesLigand-mediated TargetingPeptide DeliveryCancer Targeting LigandsPeptide Delivery SystemsPeptide-based TargetingTargeted DeliveryTargeted Delivery SystemsTherapeutic ToxicityTumor Tissue TargetingTumor-targeting Peptides
Bacteriophage MS2 was employed for targeted delivery of an apoptosis-inducing agent, Tl+, into a tumor tissue. The targeted delivery was ensured by iRGD peptide, a ligand of integrins presumably located on the surface of endotheliocytes of the tumor tissue neovasculature and certain tumor cells. The synthesized peptide was conjugated to MS2 capsid proteins. Tl+ ions from TlNO3 penetrated the phage particles and tightly bound to phage RNA. Peptide-modified MS2 preparations filled with Tl+ caused cell death in two types of cultivated human breast cancer cells and effected necrosis of these tumor xenografts in mice. Neither peptide-conjugated bacteriophage MS2 without Tl+ nor the phage filled with Tl+ but without the peptide or the same phage with the non-conjugated peptide in solution produced such effects. The preparation exhibited no acute toxicity at a therapeutic dose.
6
Structural Roles of Monovalent Cations in the HDV Ribozyme
Ailong Ke, Fang Ding, Joseph D. Batchelor et al. · Structure · 2007 · 61 citations · Full text
Nanoparticle-Delivered Chemotherapy: Old Drugs in New Packages.
Michael S. Lee, E. Claire Dees, Andrew Z. Wang · PubMed · 2017 · 55 citations
Dan Donnelly, Mirta Mihovilovic, José M. González‐Ros et al. · Proceedings of the National Academy of Sciences · 1984 · 30 citations · Full text
Medicine, Biochemistry, Pharmacology +17